Effect of methylprednisolone in reducing severe COVID-19 and mortality in high-risk patients: A retrospective study.

ABSTRACT:

Introduction

The treatment of COVID-19 patients, especially high-risk patients, remains a large challenge. Glucocorticoids have been accepted as effective medicines for severe COVID-19. However, the glucocorticoid usage guidelines do not cover all the indications for high-risk patients.

Objective

To identify more effective treatments for high-risk patients with COVID-19, this retrospective study analyzed routine epidemiological, clinical, and laboratory data from 33 high-risk patients with COVID-19 in Beijing Gobroad Boren Hospital, Beijing, China, most of whom responded well to treatment.

Methods

Severe acute respiratory syndrome coronavirus-2 infection was confirmed via real-time reverse transcriptase polymerase chain reaction assays. Outcome measures such as durati

SUBMITTER: Xiao Y 

PROVIDER: S-EPMC11384515 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature